RETIFANLIMAB for Anal squamous cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 28 adverse event reports in the FDA FAERS database where RETIFANLIMAB was used for Anal squamous cell carcinoma.

Most Reported Side Effects for RETIFANLIMAB

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	23	24.0%	8	23
Nausea	14	14.6%	3	14
Neutrophil count decreased	12	12.5%	0	12
White blood cell count decreased	12	12.5%	0	12
Disease progression	11	11.5%	10	10
Neutropenic sepsis	11	11.5%	0	11
Condition aggravated	9	9.4%	6	9
Pulmonary embolism	9	9.4%	2	9
Pyrexia	9	9.4%	0	9
Asthenia	8	8.3%	1	8
Blood sodium decreased	8	8.3%	0	8
Haematocrit decreased	8	8.3%	0	8
Malaise	8	8.3%	1	8
Monocyte count decreased	8	8.3%	0	8
Red blood cell count decreased	8	8.3%	0	8